Christoph Mack is CEO of Andrews-Cooper and has 20+ years as a technology entrepreneur with an emphasis on MedTech device missions. He was the founder and CEO of X2 Biosystems, Synapse Device Development, ReJuVey Therapeutics, WaveScan Diagnostics, and others. Christoph created more than 20 biomedical research partnerships with NCAA universities. He is the holder of 21 granted utility patents and is named on an additional 30+ pending. In addition, he has received innovation awards from ASME, IDSA, Wired Magazine, and the MDDI "Medical Device of the Year.” Christoph was named one of “Seattle’s 10 Most Influential People" by Seattle Magazine.